This study investigates advanced pancreatic cancer and non-small cell lung cancer (NSCLC).
It evaluates the safety, tolerability, and effectiveness of an investigational medication given as monotherapy to patients.
- Who can participate: Adults 18 years and older with advanced pancreatic cancer or non-small cell lung cancer, who have previously failed or cannot tolerate standard treatments, may be eligible. Participants must meet specific health criteria and agree to use effective contraception if of childbearing potential.
- Study details: Participants will receive the investigational medication through injections. A placebo is not used in this study.
- Study visits: The study requires 9 visits.